Torrent Pharmaceuticals Limited Appoints Sudhir Menon as Chief Financial Officer and Whole-Time Key Managerial Personnel, with Effect from September 1, 2018
August 31, 2018 at 12:55 am EDT
Share
Torrent Pharmaceuticals Limited announced that Shri Sudhir Menon will take over as the Chief Financial Officer and Whole-time Key Managerial Personnel of the Company with effect from September 1, 2018 consequent to the relinquishment of such position by Shri Ashok Modi who has been assigned with the other roles and responsibilities due to organizational re-structuring with effect from closing hours of August 31, 2018.
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
Torrent Pharmaceuticals Limited Appoints Sudhir Menon as Chief Financial Officer and Whole-Time Key Managerial Personnel, with Effect from September 1, 2018